October 23, 2019

October 23, 2019

Subscribe to Latest Legal News and Analysis

October 22, 2019

Subscribe to Latest Legal News and Analysis

October 21, 2019

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
23
Oct
National Safety Council States That “No Level of Cannabis Use Is Safe Or Acceptable” For Safety-Sensitive Positions Jackson Lewis P.C.
23
Oct
FDA and FTC Send Warning Letter for Marketing Unapproved Drugs and Dietary Supplements Containing CBD Keller and Heckman LLP
22
Oct
Top International News in Chemical Policy and Regulation - October 22, 2019 Bergeson & Campbell, P.C.
22
Oct
Vape Lung Disease Chills Cannabis Industry Stark & Stark
22
Oct
Opioid Update: Bellwether Settlement on Eve of Trial Squire Patton Boggs (US) LLP
22
Oct
New York Court Compels Arbitration of Commercial Marijuana Dispute Carlton Fields
22
Oct
USPTO October 2019 Patent Eligibility Guidance Update Includes New Guidance And Examples For Life Sciences Foley & Lardner LLP
21
Oct
Federal Appeals Court Holds Test For Illegal Drugs Is Not An Impermissible Medical Examination, Even If Test May Reveal Lawful Drug Use Jackson Lewis P.C.
21
Oct
PTO Releases New Guidelines on Subject Matter Eligibility Schwegman, Lundberg & Woessner, P.A.
21
Oct
Lawmaker Calls for FDA to Respond to Report on Toxic Metals in Baby Food Keller and Heckman LLP
21
Oct
FDA Warns Consumers to Stop Using THC Vaping Products Amid Ongoing Investigation into Lung Injuries Dinsmore & Shohl LLP
18
Oct
BRAG Biobased Products Blog: October 18, 2019 Bergeson & Campbell, P.C.
18
Oct
USDA Announces Renewal of Substance Exemptions in the National Organic Program Keller and Heckman LLP
17
Oct
Mexico’s Lower House Passes Front-of-Pack Labeling Bill Keller and Heckman LLP
17
Oct
California Tackles Big Pharma’s Anticompetitive ‘Pay for Delay’ Practices That Slow Down Lower-Cost Generic Drug Development MoginRubin
16
Oct
Personalized Cancer Therapy Found Nonobvious Foley & Lardner LLP
16
Oct
Pork Workers Union Sues USDA Over New Swine Slaughter Inspection System Keller and Heckman LLP
15
Oct
Not Another Puff Piece: The Difference Between Puffery and False Advertising Schiff Hardin LLP
15
Oct
EPA OIG Will Evaluate Implementation of 2009 TSCA PMN Consent Order with DuPont [Chemours] Bergeson & Campbell, P.C.
15
Oct
Federal Circuit Reverses PTAB Finding Tarceva® Method of Treatment Claims Invalid for Lack of Reasonable Expectation of Success Based on over 99.5% Failure Rate among Treatment Candidates Mintz

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Wednesday, October 23, 2019
Wednesday, October 30, 2019
Wednesday, November 6, 2019
Tuesday, November 12, 2019
Wednesday, November 13, 2019
Wednesday, November 13, 2019
Wednesday, November 13, 2019
Wednesday, December 11, 2019